Trial · NCT01688037
Adverse events55
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 55
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Double-Blind 50mg | 0 | 28 | 0 |
| other | Fatigue | General disorders | Double-Blind 100mg/50mg | 2 | 27 | 2 |
| other | Fatigue | General disorders | Double-Blind Placebo | 0 | 54 | 0 |
| other | Fatigue | General disorders | Open-Label 50mg | 0 | 93 | 0 |
| other | Fatigue | General disorders | Follow-Up | 0 | 80 | 0 |
| other | Urinary tract infection | Infections and infestations | Double-Blind 50mg | 0 | 28 | 0 |
| other | Urinary tract infection | Infections and infestations | Double-Blind 100mg/50mg | 1 | 27 | 1 |
| other | Urinary tract infection | Infections and infestations | Double-Blind Placebo | 2 | 54 | 2 |
| other | Urinary tract infection | Infections and infestations | Open-Label 50mg | 5 | 93 | 5 |
| other | Urinary tract infection | Infections and infestations | Follow-Up | 0 | 80 | 0 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Double-Blind 50mg | 2 | 28 | 2 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Double-Blind 100mg/50mg | 0 | 27 | 0 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Double-Blind Placebo | 0 | 54 | 0 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Open-Label 50mg | 0 | 93 | 0 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Follow-Up | 1 | 80 | 1 |
| other | Somnolence | Nervous system disorders | Double-Blind 50mg | 2 | 28 | 2 |
| other | Somnolence | Nervous system disorders | Double-Blind 100mg/50mg | 1 | 27 | 1 |
| other | Somnolence | Nervous system disorders | Double-Blind Placebo | 0 | 54 | 0 |
| other | Somnolence | Nervous system disorders | Open-Label 50mg | 0 | 93 | 0 |
| other | Somnolence | Nervous system disorders | Follow-Up | 0 | 80 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01688037/events